ELOXX PHARMACEUTICALS, INC. (ELOX) Operating cash flow 2016–2025
ELOXX PHARMACEUTICALS, INC. (ELOX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.3MFY2025 · since FY2016: -$8.8M → -$6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.3M | -34.2% |
| FY2024 | -$4.7M | +67.1% |
| FY2023 | -$14.3M | +55.0% |
| FY2022 | -$31.8M | +9.0% |
| FY2021 | -$35.0M | -24.3% |
| FY2020 | -$28.2M | +28.5% |
| FY2019 | -$39.4M | -25.6% |
| FY2018 | -$31.4M | -96.8% |
| FY2017 | -$15.9M | -80.2% |
| FY2016 | -$8.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice